43 results
425
EX-99.1
LGND
Ligand Pharmaceuticals Incorporated
21 Jun 22
Business combination disclosure
8:00am
Initiatives New Technologies (including new transgenic animals) TECHNOLOGIES AND INNOVATION ARE INFORMED BY DISCOVERY RELATIONSHIPS WITH OUR PARTNERS
22
8-K
EX-99.1
LGND
Ligand Pharmaceuticals Incorporated
21 Jun 22
Regulation FD Disclosure
6:19am
Initiatives New Technologies (including new transgenic animals) TECHNOLOGIES AND INNOVATION ARE INFORMED BY DISCOVERY RELATIONSHIPS WITH OUR PARTNERS
22
425
EX-99.1
8hmck6v64h8u x1c0q
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.3
ayvjg 6uslktjr
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.1
zh4ssi7iiu
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.3
8utd4l4zuxaq5ztki12
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
rj7r4u
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K
EX-99.1
jtpmth6vy3 nfn98vuc
20 Oct 20
Results of Operations and Financial Condition
10:52am